UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8 - K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of earliest event reported : July 20, 2004
Commission File Number 1-8036
WEST PHARMACEUTICAL SERVICES, INC.
(Exact name of registrant as specified
in its charter)
| Pennsylvania (State or other jurisdiction of incorporation or organization) |
23-1210010 (I.R.S. Employer Identification No.) | |
101 Gordon Drive, PO Box 645, Lionville, PA (Address of principal executive offices) |
|
19341-0645 (Zip code) |
Registrant's
telephone number, including area code 610-594-2900 | ||
N/A | ||
Former name or former address, if changed since last report.
(c) Exhibits:
Exhibit # Description
99.1 West Pharmaceutical Services, Inc. Press Release, dated July 20, 2004.
Item 12. Disclosure of Results of Operations and Financial Condition.
|
On July 20, 2004 West Pharmaceutical Services, Inc. (the “Company”) issued a press release announcing the Company’s second quarter financial results for the quarter ended June 30, 2004. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
WEST PHARMACEUTICAL SERVICES, INC. | ||
|
| ||
Date: July 20, 2004 |
/s/ William J. Federici | |
|
William J. Federici Vice President and Chief Financial Officer |
Exhibit 99.1
Exhibit Index
99.1 West Pharmaceutical Services, Inc. Press Release, dated July 20, 2004.